7/1/2013 8:00:35 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that it has been added to the Russell 3000® Index and the Russell 2000® Index as part of the annual reconstitution of the Russell indexes. The reconstitution was final after the close of the U.S. markets on June 28, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by